Oncology
Showing 151 to 200 of 294 entries
| Category | Product Name | ABC # | Size | NDC # | Manufacturer |
|---|---|---|---|---|---|
| Oncology | Mekinist™ | 10242467 | 0.5 mg/30 tabs | 00078-0666-15 | Novartis |
| Oncology | Mekinist™ | 10243572 | 2 mg/30 tabs | 00078-0668-15 | Novartis |
| Oncology | Mektovi® | 10244268 | 15 mg tab 180 | 70255-0010-02 | Pfizer |
| Oncology | Mylotarg™ | 10247475 | 4.5 mg SDV | 00008-4510-01 | Pfizer |
| Oncology | Nerlynx® | 10245134 | 40 mg tab 180 | 70437-0240-18 | Puma Biotechnology |
| Oncology | Neulasta® Onpro™ Kit | 10247542 | 6 mg/0.6 mL | 55513-0192-01 | Amgen |
| Oncology | Neulasta® Onpro™ syringe | 10244185 | 6 mg/0.6 mL | 55513-0190-01 | Amgen |
| Oncology | Nexavar® | 10247721 | 200 mg/120 tabs | 50419-0488-58 | Bayer |
| Oncology | Ninlaro® | 10251102 | 3 mg caps 3/pk | 63020-0079-02 | Millennium Rx-Ninlaro |
| Oncology | Ninlaro® | 10251126 | 2.3 mg caps 3/pk | 63020-0078-02 | Millennium Rx-Ninlaro |
| Oncology | Ninlaro® | 10251212 | 4 mg caps 3/pk | 63020-0080-02 | Millennium Rx-Ninlaro |
| Oncology | Nplate® | 10249306 | 250 mcg SDV 0.5 mL | 55513-0221-01 | Amgen |
| Oncology | Nplate® | 10249527 | 500 mcg SDV 1.0 mL | 55513-0222-01 | Amgen |
| Oncology | Nplate® | 10248169 | 125 mcg SDV 0.25 mL | 55513-0223-01 | Amgen |
| Oncology | Nubeqa® | 10247779 | 300 mg/120 tabs | 50419-0395-01 | Bayer |
| Oncology | Odomzo® | 10244506 | 200 mg/30 caps | 47335-0303-83 | Sun Pharmaceutical Industries Brand |
| Oncology | Onivyde® | 10245125 | 43 mg/10 mL SDV SOL | 15054-0043-01 | Ipsen Pharmaceuticals |
| Oncology | Opdivo® | 10247018 | 240 mg/24 mL | 00003-3734-13 | Bristol Myers Squibb |
| Oncology | Opdivo® | 10247352 | 100 mg/10 mL | 00003-3774-12 | Bristol Myers Squibb |
| Oncology | Opdivo® | 10248878 | 40 mg/4 mL | 00003-3772-11 | Bristol Myers Squibb |
| Oncology | Opdualag™ | 10266390 | 240/80 mg/20 mL SDV | 00003-7125-11 | Bristol Myers-Squibb |
| Oncology | Orserdu™ | 10276717 | 86 mg/30 tabs | 72187-0101-03 | Stemline Therapeutics |
| Oncology | Orserdu™ | 10276718 | 345 mg/30 tabs | 72187-0102-03 | Stemline Therapeutics |
| Oncology | Padcev™ | 10251153 | 30 mg SDV | 51144-0030-01 | Seattle Genetics |
| Oncology | Padcev™ | 10251165 | 20 mg SDV | 51144-0020-01 | Seattle Genetics |
| Oncology | Pemazyre™ | 10245883 | 9 mg/14 tabs | 50881-0027-01 | Incyte Corporation |
| Oncology | Pemazyre™ | 10247501 | 4.5 mg/14 tabs | 50881-0026-01 | Incyte Corporation |
| Oncology | Pemazyre™ | 10247502 | 13.5 mg/14 tabs | 50881-0028-01 | Incyte Corporation |
| Oncology | Pepaxto® | 10255002 | 20 mg INJ 1 | 73657-0020-01 | Oncopeptides |
| Oncology | Perjeta® | 10246175 | 420 mg/14 mL SDV | 50242-0145-01 | Genentech |
| Oncology | Piqray® | 10239859 | 200 mg tabs 28 blister pack | 00078-0701-84 | Novartis |
| Oncology | Piqray® | 10241941 | 250 mg tabs 56 blister pack | 00078-0715-02 | Novartis |
| Oncology | Piqray® | 10244230 | 300 mg tabs 56 blister pack | 00078-0708-02 | Novartis |
| Oncology | Polivy™ | 10247148 | 140 mg SDV | 50242-0105-01 | Genentech |
| Oncology | Portrazza® | 10244998 | 800 mg /50 mL SDV SOL | 00002-7716-01 | Eli Lilly & Co |
| Oncology | Promacta® | 10252020 | 12.5 mg PWD | 00078-0972-61 | Novartis |
| Oncology | Promacta® | 10240108 | 75 mg tab 30 | 00078-0687-15 | Novartis |
| Oncology | Promacta® | 10240112 | 25 mg tab 30 | 00078-0685-15 | Novartis |
| Oncology | Promacta® | 10240438 | 50 mg tab 30 | 00078-0686-15 | Novartis |
| Oncology | Promacta® | 10242529 | 12.5 mg tab 30 | 00078-0684-15 | Novartis |
| Oncology | Promacta® | 10248979 | 25 mg PWD | 00078-0697-61 | Novartis |
| Oncology | Provenge® | 10251231 | 250 mL | 30237-8900-06 | Dendreon Pharmaceuticals |
| Oncology | Rezlidhia™ | 10275415 | 150 mg/30 caps | 71332-0005-01 | Rigel |
| Oncology | Rituxan® | 10245307 | 100 mg/10 mL | 50242-0051-21 | Genentech |
| Oncology | Rituxan® | 10246682 | 500 mg/50 mL | 50242-0053-06 | Genentech |
| Oncology | Rituxan® Hycela | 10245088 | 1400 mg SDV | 50242-0108-01 | Genentech |
| Oncology | Rituxan® Hycela | 10244524 | 1600 mg SDV | 50242-0109-01 | Genentech |
| Oncology | Rozlytrek™ | 10246143 | 200 mg/90 caps | 50242-0094-90 | Genentech |
| Oncology | Rozlytrek™ | 10245334 | 100 mg/30 caps | 50242-0091-30 | Genentech |
| Oncology | Rubraca® | 10249152 | 300 mg/60 tabs | 69660-0203-91 | Clovis Oncology |